Israeli generic drugmaker hires former Novartis executive Richard Francis to take over as new CEO starting January 1

Generic drugmaker says it agreed to contribute sum in cash and medications to states, local governments and tribes for its role in epidemic

In latest settlement, like past ones, US subsidiary of Israeli generic drugmaker to provide over $84m worth of treatment medicines

Agreement will see US subsidiary of Israeli generic drugmaker also provide over $78m worth of treatments that aid in addiction treatment and prevention

Agreement with US subsidiary of Israeli pharmaceutical giant also includes $75m provision of generic medicine doses that aid in opioid addiction and recovery

Israeli pharma giant signs agreement with Cannbit-Tikun Olam to produce THC and CBD oils for Israeli, Palestinian Authority markets

Calcalist: The tender will help redeem debentures the pharmaceutical firm issued to fund the $40.5 billion acquisition of Actavis in 2016

Herzliya- and San Francisco-based company with ties to medical giant Teva developing drug to treat NASH, a severe liver disease

Israeli generic drug manufacturer named as 'consistent participant' in conspiracies to raise prices, sometimes by more than 1000%; executives said to have obstructed investigation

Israeli pharmaceutical company gets OK from US regulators for its version of Narcan